Nitric oxide level and von Willebrand factor (vWF) secretion are not candidate markers of endothelial cell dysfunction in adenosine triphosphate (ATP) depleted endothelial cells by Behjati, M et al.
African Journal of Biotechnology Vol. 10(44), pp. 8871-8876, 15 August, 2011     
Available online at http://www.academicjournals.org/AJB 
DOI: 10.5897/AJB10.2329 




Full Length Research Paper 
 
Nitric oxide level and von Willebrand factor (vWF) 
secretion are not candidate markers of endothelial cell 
dysfunction in adenosine triphosphate (ATP) depleted 
endothelial cells 
 
Mohaddeseh Behjati1*, Mohammad Hashemi1, Mohammad Kazemi2 and Mansoor Salehi3 
 
1
MD, Isfahan University of Medical Sciences, Isfahan, Iran. 
2
M.Sc. in Molecular Biology, Isfahan University of Medical Sciences, Isfahan, Iran. 
3
PhD in Molecular Biology, Isfahan University   of Medical Sciences, Isfahan, Iran. 
 
Accepted 14 March, 2011 
 
Endothelial cells under physiological conditions can alter energy balance by alteration in synthesis, 
metabolism and transport of adenosine triphosphate (ATP), which failed during endothelial cell 
dysfunction. ATP depleted endothelial cells are unable to perform their physiological functions as 
energy dependent protein secretion. Isolated human umbilical vein endothelial cells (HUVEC) from fresh 
umbilical cords were treated with 10 mM 2-deoxyglucose and 0.1 pg/ml of oligomycin for 6 h to induce 
ATP depletion. Nitric oxide (NO), von Willebrand factor (vWF), lactate dehydrogenase (LDH) release and 
trypan-blue exclusion were compared between treated and untreated cells. We observed a slight 
decrease in nitric oxide levels (P = 0.09) and vWF (P = 0.395) in the setting of 49.36% ATP depletion. 
There was no significant change in LDH release and cell viability between treated and untreated cells (P 
> 0.05). Since vWF exocytosis is an energy consuming process, decreased secretion of vWF in the 
isolated near-half percent of ATP depletion is not seemingly at odds. The application of vWF exocytosis 
fades as a candidate marker for ATP depletion induced injury, in cultured endothelial cells. Nitric oxide 
level and vWF secretion are not candidate markers of endothelial cell dysfunction in isolated partial 
ATP- depleted HUVECs. Measures such as arachidonic acid synthesis may be better alternatives. 
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and transport of adenosine triphosphate (ATP) (Buxton 
et  al,  2001;  Arakaki  et  al.,  2003).  These  cells release 
Purinergic nucleotides that are then hydrolyzed to 
adenosine diphosphate (ADP) and adenosine by the act 
of ectonucleotidase (Kolosova et al., 2005). The released 
ATP acts as a protective agent in the maintenance of 
endothelial cell integrity via its barrier-keeping function 
(Kolosova et al., 2005). The generated adenosine is a 
potent autacoid, which prohibits untoward platelet 
activation and thrombus formation (Bassenge, 1989). In 
addition, adenine nucleotides modulate the release of 
endothelial-derive relaxing factors and hence play an 
important role in flow-mediated arterial vasoregulation 
(Choi and Barakat, 2004). 
In  the  process   of  endothelial cell  dysfunction, herald  




mechanism toward atherosclerosis and endothelial cells 
fail to keep their energy balance state. This alteration is 
due to oxidative mitochondrial dysfunction, oxidized low-
density  lipoprotein (ox-LDL) and inflammatory or hypoxic  
injuries (McCully, 2009; Schmitt, 1995; Hultén and Levin, 
2009). This energy depletion put cells in energy crisis 
which mutually results in further mitochondrial damage by 
accumulation of reactive species. The inactivated 
ectonucleotidase activity, mainly CD39, results in increased 
vascular level of ADP and limited bioavailability of 
adenosine, which is associated with increased platelet 
aggregation and vasoconstriction (El-Omar et al., 20058; 
Burnstock, 1987). Energy depletion makes cells suscepti-
ble to further injuries, a synergistic factor, which threatens 
health of the cell and its neighbors; hence they lose 
energy for defense. Depletion of ATP, major conseq-
uence of ischemia disrupts the normal transmembrane 
ionic gradients and ion channels, which leads to 
accumulation of sodium and calcium in intracellular and K 
in extracellular space (Hinshaw et al., 1988; Siesjö, 1992; 
Köppel et al., 1998). The impaired function of ATP-
regulated channels, detrimental in the control of cell 
membrane polarization, is evident by depolarized state of 
dysfunctional cells (Figura et al., 2009).   
Endothelial cell dysfunction is associated with reduced 
nitric oxide (NO) release (Florea and Blatter, 2008). 
Increased plasma levels of von Willebrand factor (vWF) 
were also detected in endothelial cell dysfunction, but it is 
not evaluated in endothelial cells exposed to isolated 
ATP depleted endothelial cells. As a matter of fact, vWF 
secretion from endothelial cells is an ATP dependent 
process, which is expected to be inhibited in ATP depleted 
endothelial cells (Vischer, 2006). Based on these data, it 
seems unreasonable to use vWF release, a widely used 
marker of endothelial cell dysfunction, in each setting. 
Application of vWF as a marker of endothelial cell dys-
function seems questionable in cultured endothelial cells, 
with the absence of platelets and ischemic tissue, as 
other sources of vWF.  
Therefore, this study was performed to evaluate the 
role of ATP depletion on the NO levels and vWF secretion 
in endothelial cells, and their efficacy as candidate 
markers of endothelial cell dysfunction in vitro.   
 
 
MATERIALS AND METHODS 
 
Cell isolation and culture  
 
Human umbilical vein endothelial cells (HUVEC) were isolated from 
fresh umbilical cords as described previously. Briefly, human 
umbilical cords were obtained by written consent; with approval 
from Institutional review committee of Isfahan University of Medical 
Sciences. Cells were cultured in M199 culture medium (Gibco-BRL, 
Scotland) in T25 flasks coated with gelatin (1%). Confluent 
monolayers were passed using Trypsin/ ethylenediaminetetraacetic 
acid (EDTA) (Sigma- Aldrich, St. Louis, MO). Morphology of 
HUVEC monolayer was examined by a phase contrast microscope 
(Motic digital microscopes equipped with Moticam digital 





performed by the expression of CD31 (PECAM) on their surface 
which was measured by flow cytometry analysis after staining with 
phycoerythrin-conjugated murine monoclonal anti-human 
antibodies (eBiosciences, San Diego, CA, U.S.A.). All experiments 




Induction of ATP depletion 
 
HUVECs were treated with 10 mM 2-deoxyglucose (2DG), a 
glycolytic inhibitor, and 0.1 pg/ml of oligomycin (OG), a respiratory 
chain inhibitor, to induce ATP depletion and incubated at room 
temperature, in phosphate buffered saline (PBS). The applied dose 
of these agents was based on the dose-response curve of these 
compounds (data not shown). According to the previous study 
carried out by Revtyak et al. (1992), the simultaneous application of 
these agents were associated with partial ATP-depletion without 
induction of apoptosis or necrosis. So with the application of this 
method, the desired ATP-depletion amount is less than 50%. After 
6 h, culture media was removed and cells were washed with PBS.  
 
 
Assay of cellular ATP/ADP 
 
In order to assess the induced ATP depletion, cellular ATP, ADP 
and ADP/ATP ratio were measured by the ApoSENSOR
TM
 
ADP/ATP Ratio Assay Kit (Biovision, USA), in induced and un-
induced cells in 96-well plates. Adenine nucleotides were measured 
by quantified chemiluminescent signals read out using a CentroLIA 
LB 961 plate Luminometer (Berthold Technologies, Germany). The 
quantified signals were expressed in Log10 relative light units (RLU). 
Morphological changes after ATP depletion were assessed by 
phase contrast microscope and viable cells were counted after 
staining with trypan blue.  
 
 
Lactate dehydrogenase (LDH) assay 
 
In order to determine membrane disintegration and increased 
permeability, LDH levels were measured in test and control cells. 
The supernatant LDH of treated and untreated HUVECs in 96-well 
plates were assayed, based on the reduction of NAD
+
 at 339 nm, 





NO in cell-conditioned medium was measured indirectly by 
quantification of nitrites, using the total nitric oxide and nitrate/nitrite 
parameter assay kit according to manufacturer's instructions (R&D). 






Extracellular vWF was measured in HUVECs in 96-well plates 
before and after ATP depletion using Asserachrom vWF Kit 




ATP-dependent ion transport 
 
In order to evaluate the induced ionic changes after ATP depletion 
in HUVECs, the extracellular Na and K were measured by emission 
flame photometry before and after ATP depletion.   













Figure 2. Influence of 2-deoxyglucose and oligomycin treatment on 
cellular ATP and ADP levels in HUVECs. The amounts of ATP 
(black bars) and ADP (grey bars) were assessed in HUVEC cells 
before and after 6 h of treatment with 2-deoxyglucose and 
oligomycin. The results are expressed as Log10 relative light units 






Data  representations  and  statistical  tests  were  made with paired 
samples Student's t-test using the Statistical Package for the Social 
Sciences (SPSS) software Ver. 15. P-value less than 0.05 was 





Induction of ATP depletion by simultaneous 
application of 2DG and OG  
 
The study was based on  the  HUVEC  cells,  well  known 
cells  in  terms  of  endothelial  cell injury and dysfunction. 
Cells were verified as endothelial cells by their polygonal 
cobblestone morphology. Phase contrast microscopic 
photographs of the cultured endothelial cells are shown in 
Figure 1. Flow cytometry results demonstrated that cells 
were stained positively with anti-CD31 antibody. By 
simultaneous application of 2DG and OG, 49.36% ATP 
depletion was induced in the treated cells and cellular 
ADP demonstrated a 45% increase in treated when 
compared with untreated cells. ADP/ATP ratio was 0.51 
in untreated cells which increased to 3.33 after treatment 
with 2DG and OM. These data are mostly in favor of 
growth arrest (Figure 2). There was no difference in the 
cell number between treated and untreated cells, counted 
by trypan blue exclusion within 15 min (92.66 ± 1.11 vs. 
96.36 ± 0.53% per 40 mm dish, P = 0.071, n = 3). After 6 
h of ATP depletion, some endothelial cells appeared round 
and retracted. Only a few numbers of ATP-depleted 
endothelial cells were detached from the culture media 
and large gaps were seen between endothelial cells. 
There was no difference in LDH release between treated 
and untreated cells (7.40 ± 0.56 vs. 7.55 ± 0.07 IU/L, P = 
0.75, n = 3), which is in favor of intact membrane and 
absence of the necrotic events in ATP depleted 
endothelial cells (Table 1).  
 
 
ATP depletion decreases NO levels and vWF 
secretion in HUVECs 
 
There was a slight decrease (16.32%) in NO levels bet-
ween induced and un-induced endothelial cells (7.23 ± 
1.13 vs. 8.64 ± 0.85 µm/L, P = 0.09, n = 3). In addition, 
our  results  demonstrated a marginal decrease (15.73%) 
in secreted vWF between treated and untreated cells  




Table 1. Effect of ATP depletion on NO level, vWF secretion, LDH 




Mean ± SD 
Before After 
NO 8.64 ± 0.85 7.23 ± 1.13 
vWF 0.087 ± 0.008 0.105 ± 0.023 
LDH 7.55± 0.07 7.40 ± 0.56 
Na 158.3± 1.52 138.3 ± 1.52* 
K 4.40 ± 0.1 3.83± 0.05* 
 
Primary  cultures  of HUVECs in 96-well plates were incubated  for 6 h 
in the absence and presence of 10 mM 2-deoxyglucose (2DG)  and  0.1 
pg/ml  oligomycin  (OG)  in PBS buffer , pH  7.4 at 37°C. NO level, vWF 
secretion, LDH release and extracellular Na/K were assessed before 
and after ATP depletion. Data are expressed as the mean ± S.D for 




(0.0876 ± 0.0087 vs. 0.1056 ± 0.023885 µm/L, P = 0.395, 
n = 3) (Table 1). 
 
 
Altered ionic gradient in ATP depleted HUVECs  
 
A significant decrease in extracellular Na was observed 
between induced and un-induced endothelial cells (138.33 
± 1.52 vs. 158.33 ± 1.52 mEq/L, P = 0.006, n = 3). This 
decrease (12.63%) is in parallel with inhibition of 
Na/K/ATPase pump. Interestingly, a significant decrease 
(12.95%) in extracellular K level was also seen in ATP 
depleted cells when compared to normal ATP level cells 
(3.8333 ± 0.057 vs. 4.4000 ± 0.100mEq/L, P = 0.023, n = 





In our experiment, vWF factor was slightly decreased 
(15.73%) in ATP-depleted endothelial cells. Hence, it is 
considered as a marker of endothelial cell dysfunction 
and we expected it's secretion to be increased. vWF 
functions (Holmsen, 1994) and its exocytosis from endo-
thelial cells are shown to be an ATP-dose dependent 
process (Hegeman et al., 1998) and Consequently, after 
ATP depletion, vWF exocytosis will be impaired and 
decreased vWF secretion in this setting, is explainable by 
its energy dependent protein exocytosis.  
Enhanced vWF exocytosis is seen in the HUVECs 
exposed to isolated acute hypoxia, in contrast to human 
retinal endothelial cells which showed decreased vWF 
secretion under oxygen-glucose deprivation (Kim et al., 
2007). It seems that the secretion of vWF in response to 
endothelial cell stimulants is different by endothelial cells 
with various origins, but the importance of this difference 
needs to be determined. High levels of cytokines in vitro 
were  not  able  to  raise  the  secretion  of vWF in treated  





rent stimuli on vWF exocytosis (Zavoico et al., 1989). 
Considering energy depletion as a cellular insult with 
effects on vWF secretion, the effects of isolated meta-
bolic inhibition on the vWF exocytosis pattern in HUVECs  
needs to be determined. ATP and its metabolites exert an 
agonist-induced exocytosis of vWF (Parker and Gralnick, 
1997). Contrarily, ATP depletion acts as an antagonist-
inhibited exocytosis of vWF (Dorner et al., 1990). So, 
enhanced vWF exocytosis from dysfunctional endothelial 
cells is not attributable to energy crisis and we suggest 
that other stimuli such as membrane shedding may pro-
voke it. On the other hand, activated platelets and 
reperfused ischemic tissues may be source of secreted 
vWF which are absent in studies on HUVECs. Also, for 
endothelial cells, it has been demonstrated that vWF 
secretion in platelets is an ATP-dependent process which 
is decreased in the ATP-depleted settings (Parker and 
Gralnick, 1997). However, it seems that vWF is not a 
candidate marker of endothelial cell dysfunction in the 
setting of ATP depletion induced endothelial cell injury.  
Lines of evidences demonstrated that NO level 
decreases in dysfunctional endothelial cells, a favored 
index of endothelial cell dysfunction (Kawai et al., 1996). 
But interestingly, NO level has never been measured as 
a marker of endothelial cell dysfunction in isolated ATP 
depleted HUVECs. In our experiment, 16.32% decrease 
in NO level was observed in ATP depleted when com-
pared to untreated cells. This statistically non-significant 
change in NO level may be due to the fact that constellation 
of insults are needed for impairment of endothelial cell 
function, hence endothelial cells are considered as resis-
tant cells to imposed stresses. Isolated ATP depletion 
may lead to aberrant endothelial cell function, syner-
gistically, with other stressors especially by predisposing 
cells to further injuries. It seems that isolated partial 
energy deprivation may be tolerable or even considered 
as a sub-lethal injury by cells. The threshold of 
endothelial cell injury needed to perturb NO activity is not 
well determined, but it seems that depletion of near fifty 
percent of ATP stores is less pronounced to induce 
dramatic fall in NO production. This level of ATP 
depletion for cells in conditioned medium will be certainly 
different from in vivo conditions with complex interplay 
microenvironment. Determination of the threshold of ATP 
depletion perquisite for induction of lethal cellular injury, 
measurable by impaired NO production may be helpful 
for better understanding of ischemia and reperfusion 
injuries. 
Consistent with previous data, isolated partial ATP 
depletion has not been associated with induction of 
apoptosis or necrosis of endothelial cells, as demon-
strated by the percentage of viable cells and LDH release 
from treated cells (Revtyak and Campbell, 1992). Six hours 
of ATP deprivation, induced by simultaneous appli-cation 
of 2-DG and OG, is shown to be associated with 
endothelial cell dysfunction, determined by impaired 
synthesis  of  arachidonic  acid  (Revtyak  and  Campbell, 





50% ATP depletion to prevent cell death. Statistically, 
non-significant changes of NO and vWF secretion in our 
study demonstrated that candidate markers of endothelial  
cell dysfunction should be sought in vitro based on design 
of the experiment, not universally.  
ATP depletion is considered as a key factor in the 
disruption of normal cellular transmembrane ionic gradient 
(Pepe, 2000). Decreased extracellular concentration of Na, 
an indirect measure of increased intracellular retention, is 
in accordance with Na/K/ATPase pump failure under 
hypoxic conditions (Palpant et al., 2008; Kawai et al., 
1996). Intracellular alteration of Na and calcium concen-
trations following ATP depletion is associated with 
activation of inwardly rectifier K channels (KIR) of high 
conductance, to facilitate cell membrane re-polarization 
(Lien et al, 2003; Mintert  et al., 2007; Harrell et al., 2007; 
Pouget, 2008). During hypoxia, ischemia or metabolic 
inhibition, ATP-dependent K channels (KATP) open, which 
facilitate K influx and shortening of action potential dura-
tion (Harrell, 2007; Pouget, 2008; Lebuffe et al., 2003; 
Cameron et al., 2003; Lascano et al., 2002). Therefore, 
reduced extracellular K concentration, following ATP 
depletion seems to be due to the activation of ATP-
dependent KIR channels, located in the membrane of 
endothelial cells (Cameron et al., 2003; Hu et al., 2003). 
The other explanation for reduced extracellular K concen-
tration might be increased K uptake through Na-K-Cl 
cotransport, as seen in rat brain capillary endothelial cells 
(RBECs) under hypoxic conditions (Kawai et al., 1996). 
Membrane alteration may precede alterations in 
cytoplasm and nucleus. Pump failure and membrane 
dysfunction may be the earlier events in the process of 
endothelial cell dysfunction, proceeding NO impairment 
and vWF exocytosis.  
The cascade of events involved in the process of ATP-
depletion induced endothelial cell dysfunction, are not 
clearly identified. Further studies are needed to clarify 
the role of vWF exocytosis in the stressful conditions 
provided by isolated energy crisis for endothelial cells. 
Regulated secretion of vWF in graded ATP-depleted 
endothelial cells may give us a comprehensive insight 
in this regard. The lethal dose of ATP depletion for 
endothelial cells is more than 50%. But the exact 
threshold needs to be determined by the grade of ATP 
depletion associated with impaired NO production. 
Besides, earlier markers of endothelial cell dysfunction 
should be sought, which proceed impaired NO 
production. So, measures such as ionic transport 
pump failure and arachidonic acid synthesis, as earlier 
markers of endo-thelial cell dysfunction, may be better 
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